Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Clinical trials have used doses of 25-30 nmol/kg by IV infusion (Schneider-Helmert et al., 1981Subcutaneous administration and oral intestinal absorption have also been studied
Association between PI3K/AKT-mTOR and MYC Targets V2 activity (GSVA) and primitive / committed status
Case, D
Holstein A, Plaschke A, Egberts EH
J Mol Biol 134:199218
As always, any unusual symptoms or concerns should be brought to the attention of a healthcare provider as soon as possible
US$ 20.30
US$ 27.11
US$ 24.98
US$ 26.41
US$ 22.03
